SAN ANTONIO--(BUSINESS WIRE)--Dec 12, 2024--. bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need ...
News
- bioAffinity Technologies Set for Continued Expansion in 2025 | News | bakersfield.com
- Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer ...
... San Antonio Breast Cancer Symposium, held ... Monte Rosa Therapeutics is a clinical-stage biotechnology ... Vector Illustration of pharmacy drug health ...
- Holland & Knight Expands Intellectual Property Group with Addition of Partner Kenneth ...
His practice covers various industries, including biotech ... degree in physiology from The University of Texas Health Science Center at San Antonio and ...
- Ibrance combination extends median PFS in breast cancer group | The Pharmaletter
12 December 2024. More on this story... Pfizer's rollercoaster ride and what comes next · Biotechnology.
- Stirista Climbs to #4 on San Antonio Business Journal's 2024 Fast Track Awards
Biotechnology · Clinical Trials & Medical Discoveries · Dentistry · FDA ... San Antonio Business Journal's Fast Track Awards for 2024. This marks ...